July 31, 2014 11:28 PM ET

Life Sciences Tools and Services

Company Overview of Sanford-Burnham Medical Research Institute

Company Overview

Sanford-Burnham Medical Research Institute, a laboratory-based life sciences research company, conducts collaborative research to find cures for human disease. It discovers the fundamental molecular causes of disease and devises the therapies of tomorrow; studies normal cellular processes and what causes them to go awry; uncovers the molecular basis of various rare inherited genetic diseases; engages in stem cell research and drug discovery; and studies type 1 diabetes, or cardiac and skeletal muscle disorders. The company was formerly known as Burnham Institute for Medical Research and changed its name to Sanford-Burnham Medical Research Institute in February 2010. Sanford-Burnham Medical R...

10901 North Torrey Pines Road

La Jolla, CA 92037

United States

Founded in 1976

Phone:

858-646-3100

Fax:

858-646-3199

Key Executives for Sanford-Burnham Medical Research Institute

Interim Chief Executive Officer
Chief Financial Officer
Associate Director of Scientific Communications
Vice President of Business Development
Compensation as of Fiscal Year 2014.

Sanford-Burnham Medical Research Institute Key Developments

Sanford-Burnham and Daiichi Sankyo Collaborate to Develop Cardiovascular Drugs

Sanford-Burnham Medical Research Institute and Daiichi Sankyo Co. Ltd. have entered into a three-year comprehensive alliance to develop therapeutics for the treatment of cardiovascular-metabolic diseases. This collaboration focuses on identifying, validating, and screening novel drug targets, and studying new mechanisms of disease. The Sanford-Burnham team will identify and validate targets in collaboration with Cardiovascular-Metabolics Research Laboratories at Daiichi Sankyo. After the validation of the targets, collaboration teams will conduct drug screening to identify compounds that modulate the targets using facilities at both sites.

Sanford-Burnham Medical Research Institute Signs Contract with Daiichi Sankyo

Sanford-Burnham Medical Research Institute has signed a three-year comprehensive alliance with Daiichi Sankyo. It was reported May 22, 2014 that the contract has been signed for the development of first-in-class therapeutics indicated to treat cardiovascular-metabolic diseases. It is aimed at identifying, validating, and screening novel drug targets and studying new mechanisms of disease. The team at Sanford-Burnham will identify and validate targets in partnership with Cardiovascular-Metabolics Research Laboratories at Daiichi Sankyo.

Sanford-Burnham Medical Research Institute and Daiichi Sankyo Company, Limited Form Alliance to Study Novel Drug Targets in Cardiovascular-Metabolic Diseases

Sanford-Burnham Medical Research Institute and Daiichi Sankyo Co. Ltd. announced they have entered into a three-year comprehensive alliance to develop first-in-class therapeutics for the treatment of cardiovascular-metabolic diseases. The collaboration is built on an open-innovation model to bridge the gap between target discovery and pre-clinical drug development. This collaboration focuses on identifying, validating, and screening novel drug targets, and studying new mechanisms of disease. The Sanford-Burnham team will identify and validate targets in collaboration with Cardiovascular-Metabolics Research Laboratories at Daiichi Sankyo. After the validation of the targets, collaboration teams will conduct drug screening to identify compounds that modulate the targets using facilities at both sites.

Similar Private Companies By Industry

Company Name Region
Inception Sciences, Inc. United States
EMD Millipore Corporation United States
Avails Medical, Inc. United States
Coulbourn Instruments, LLC United States
Calbiotech, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sanford-Burnham Medical Research Institute, please visit www.sanfordburnham.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.